Life sciences translation experts

Market Access & HEOR Translation Services

Regulatory approval is only the first step of getting your new medical device or drug to market. Market Access and Health Economics and Outcomes Research (HEOR) teams are responsible for proving a product’s value and ensuring therapies are paid for and adopted by payers worldwide (e.g., government bodies, private insurers, etc.). Without clear, accurate value communication, even approved drugs, biologics, and medical devices can be delayed or denied access to markets.

Conversis, an IQVIA business, delivers specialist translation services for Market Access and HEOR, helping you communicate clinical and economic evidence with confidence. From HTA dossiers and global value submissions to payer materials, economic models, real-world evidence, and patient-reported outcomes, we ensure your data is understood by decision-makers in every market.

With experienced life sciences linguists, deep HEOR expertise, and proven global scale, Conversis helps you accelerate reimbursement, reduce delays, and maximize market uptake, so your therapies reach patients faster.

The Translation Challenges in Market Access & HEOR.

Complex Global Requirements

Market Access often involves submissions to multiple countries, each with its own Health Technology Assessment (HTA) body (e.g., NICE in the UK, IQWiG/G-BA in Germany, HAS in France). These agencies typically require evidence (clinical data, economic models and outcomes studies) to be submitted in the local language.

Localization Requirements

Clinical Outcome Assessment (COA) instruments, such as patient surveys and PROs, must be accurate and culturally valid. Many HTA agencies require results to be presented in the local language.

Costly Delays

Materials include HTA dossiers, global value dossiers, reimbursement slide decks, economic models, and patient-reported outcome data. These materials must be precise: mistranslations or mistakes can slow approvals, reduce credibility, and create costly delays that affect revenue.

How Conversis Solves These Challenges.

At Conversis, we offer end-to-end translation and localization tailored to Market Access and HEOR teams.

Our translators are native speakers with in-depth expertise in pharmaceuticals, biotechnology, and health economics, enabling them to capture the nuanced terminology and conventions required by payers. We also provide terminology management and quality assurance specific to HEOR content (ensuring consistency across value models, COA instruments, and PRO tools)

HEOR Materials We Can Help With.

HTA dossiers and submissions (including local and global formats)
Global Value Dossiers (GVDs)
EU Joint Clinical Assessment (JCA) documents
Payer materials and reimbursement presentations
Formulary submissions and payer dossiers
Economic models and cost-effectiveness analyses
Economic and value narrative summaries
Real-world evidence (RWE) reports and analyses
RWE source materials (EHRs, physician notes, claims data, registries)
Clinical Outcome Assessment (COA) Instruments, such as patient-reported outcomes (PRO) questionnaires
Patient surveys, diaries, and digital study tools
Literature reviews
HTA and payer responses, clarifications, and written Q&As
Payer and HTA meeting materials
Post-launch evidence studies and local market publications
Scientific publications (abstracts, posters, manuscripts)
Internal training, guidance, and methodological materials

The Key Benefits of Partnering With Conversis.

Life sciences expertise: All Conversis linguists are subject matter experts, ensuring highly-accurate translations that support faster approvals and confident regulatory and reimbursement submissions.

Proven and trusted: We are ISO 9001, ISO 17100, and ISO 27001 certified, with over 20 years’ experience delivering regulatory and life sciences translation services.

True global scale: Our network of 3,000+ native linguists supports translation in 330+ language combinations, providing complete global coverage for your Market Access and HEOR needs.

Your one strategic partner: We regularly manage complex, multi-market projects across 80+ languages and 50+ therapeutic areas, making Conversis your single, end-to-end translation partner.

Speed without compromise: We combine hands-on project management with AI-enabled workflows to remove bottlenecks, accelerate turnaround times, and maintain the highest quality standards.

Get in touch

Trusted by Life Sciences Organizations Globally

What Our Clients Say About Working With Us.

“I know some of the requests on these studies have not been typical and we have asked a lot of Conversis, but you really have stepped up and delivered. With your attention to detail, knowledge of the processes, diligence, and hard work to ensure the job gets done, you have made a significant impact on the work we are able to deliver here at IQVIA.”

Shelby Terry, Senior Patient Recruitment Specialist at IQVIA

“I really appreciate you looking for ways to get this project over the line, and for your patience in explaining the processes to me. You guys make translations so much less stressful than my experiences before. Thank you!”

Key Account Manager, Global Pharmaceuticals Company

“The team was always approachable throughout the entire project and worked effectively so that we were able to meet our tight deadline. The linguist’s understanding of the biology and technical aspects of the project resulted in the production of a highly competent translated document. We can therefore only recommend their work.”

Silke Fuchs, Regulatory Scientist at Target Malaria